Biochemical Pharmacology 1991: Vol 41 Table of Contents

25 Pages·1991·7.2 MB·English

BIOCHEMICAL
PHARMACOLOGY
AN INTERNATIONAL JOURNAL
(FOUNDED BY SIR RUDOLPH A. PETERS)
VOLUME 41, 1991
VOLUME CONTENTS AND AUTHOR INDEX
©
PERGAMON PRESS
OXFORD - NEW YORK - SEOUL - TOKYO
BIOCHEMICAL PHARMACOLOGY
EDITORIAL BOARD
Chairman: A. D. WELCH
Regional Editors
European Continent
Prof. PETER ALEXANDER Biochemical Pharmacology U.K. Office, P.O. Box 11, Cullompton, Devon
(Executive Editor) EX15 1TQ, U.K.
Prof. J. GIELEN Université de Liége, Laboratoire de Chimie Médicale, Institut de Pathologie,
B-4000 Sart-Tilman par Liége 1, Belgium
Associate Editors
Prof. MARTIN K. CHuRCH Clinical Pharmacology, Centre Block, Southampton General Hospital, Southamp-
ton SO9 4XY, U.K.
Dr. PIERRE LADURON Département de Biologie, Rhéne-Poulenc Santé, Centre de Recherches de Vitry,
13, quai Jules Guesde, 94403 Vitry sur Seine, France
American Continent
Prof. ALAN C. SARTORELLI Yale University School of Medicine, Department of Pharmacology, Sterling Hall of
Medicine, 333 Cedar Street, P.O. Box 3333, New Haven, Connecticut 06510-8066,
U.S.A.
Associate Editors
Prof. YUNG-CHI CHENG Yale University School of Medicine, Department of Pharmacology, Sterling Hall of
Medicine, 333 Cedar Street, P.O. Box 3333, New Haven, Connecticut 06510-8066,
U.S.A.
Prof. PRiscILLA S. DANNIES Yale University School of Medicine, Department of Pharmacology, Sterling Hall of
Medicine, 333 Cedar Street, P.O. Box 3333, New Haven, Connecticut 06510-8066,
U.S.A.
Prof. R. H. RoTH Yale University School of Medicine, Department of Pharmacology, Sterling Hall of
Medicine, 333 Cedar Street, P.O. Box 3333, New Haven, Connecticut 06510-8066,
U.S.A.
Dr. B. Z. RENKIN Yale University School of Medicine, Department of Pharmacology, 47 College
Street, Suite 226, New Haven, Connecticut 06510-3209, U.S.A.
Commentaries Editor
Prof. C. NORMAN GILLIS Yale University School of Medicine, Departments of Anesthesiology and Pharma-
cology, Sterling Hall of Medicine, 333 Cedar Street, P.O. Box 3333, New Haven,
Connecticut 06510-8066, U.S.A.
Software Survey Section Editor
Dr. Davip STAGG Yale University School of Medicine, Biomedical Computing Unit, 333 Cedar
Street, P.O. Box 3333, New Haven, Connecticut 06510-8066, U.S.A.
Microform Subscriptions and Back Issues: Back issues of all previously published volumes, in both hard copy and on microform,
are available direct from Pergamon Press offices.
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously
submitted or published elsewhere. By submitting a manuscript, the authors agree that the copyright for their article is transferred
to the publisher if and when the article is accepted for publication. However, assignment of copyright is not required from authors
who work for organisations which do not permit such assignment. The copyright covers the exclusive rights to reproduce and
distribute the article, including reprints, photographic reproductions, microform or any other reproductions of similar nature
and translations. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by
any means, electronic, electrostatic, magnetic tape, mechanical, photocopying, recording or otherwise, without permission in
writing from the copyright holder.
Whilst every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement
appears in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein
are the sole responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editorial board and editors
and their respective employees, officers and agents accept no responsibility or liability whatsoever for the consequences of any
such inaccurate or misleading data, opinion or statement.
Photocopying information for users in the U.S.A. The Item-Fee Code for this publication indicates that authorization to photocopy
items for internal or personal use is granted by the copyright holder for libraries and other users registered with the Copyright
Clearance Center (CCC) Transactional Reporting Service provided the stated fee for copying, beyond that permitted by Section
107 or 108 of the United States Copyright Law, is paid. The appropriate remittance of $3.00 per copy per article is paid directly
to the Copyright Clearance Center Inc., 27 Congress Street, Salem, MA 01970.
Permission for other use. The copyright owner’s consent does not extend to copying for general distribution, for promotion, for
creating new works, or for resale. Specific written permission must be obtained from the publisher for such copying.
In case of doubt, please contact your nearest Pergamon Press office.
The Item-Fee Code for This Publication is: 0006-2952/91 $3.00 + 0.00
@m The paper used in this publication meets the minimum requirements of American National Standard for Information
Sciences—Permanence of Paper for Printed Library Materials, ANSI Z39.48-1984.
Publishing and Advertising Offices: Headington Hill Hall, Oxford OX3 OBW (Oxford 794141), and 395 Saw Mill
River Road, Elmsford, NY 10523. Published twice monthly. Annual Institutional subscription rate (1991)
DM 3816.00. 2-year Institutional rate is available on request. Personal subscription rate for those whose library
subscribes at the regular rate is available on request. Subscription rates for Japan include despatch by air and
prices are available on application. Prices are subject to change without notice. Subscription enquiries from
customers in North America should be sent to: Pergamon Press Inc., 395 Saw Mill River Road, Elmsford,
NY 10523, U.S.A., and from the remainder of the world to: Pergamon Press plc, Headington Hill Hall,
Oxford OX3 OBW, U.K.
Copyright © 1991 Pergamon Press plc
EDITORIAL ADVISORY BOARD
American Continent
JuLius AxELRoD—National Institutes of Health, Bethesda, YUTAKA KOBAYASHI—Ko-By Associates, 60 Audubon Road,
Wellesley, MA
MICHAEL R. BoypD—Developmental Therapeutics Program, WALTER M. LovENBERG—Marion Merrell Dow Research In-
National Cancer Institute, Executive Plaza North, stitute, Cincinnati, OH
Rockville, MD P. N. MAGeEE—Temple University School of Medicine,
EDWARD BrRESNICK—Department of Pharmacology and Toxi- Philadelphia, PA
cology, Dartmouth Medical School, Hanover, NH G. J. MANNERING—Department of Pharmacology, University
D. N. BRINDLEY—Faculty of Medicine, University of Alberta, of Minnesota Medical School, Minneapolis, MN
Edmonton, Canada TaG E. MANsouR—Department of Pharmacology, Stanford
MICHAEL J. BROWNSTEIN—National Institutes of Health, University Medical Center, Stanford, CA
Bethesda, MD PauL B. McCay—Oklahoma Medical Research Foundation,
JACK R. CooperR—Yale University School of Medicine, New Oklahoma City, OK
Haven, CT HERBERT Y. MELTZER—Case Western Reserve University,
JaMEs K. Cowarp—College of Pharmacy, University of Cleveland, OH
Michigan, Ann Arbor, MI EsTEBAN MeézeY—Johns Hopkins University School of
IAN CreEsE—Center for Molecular and Behavioral Neuro- Medicine, Baltimore, MD
science, 195 University Avenue, Newark, NJ DaNiEL W. NEBERT—Department of Environmental Health,
JOHN W. DALY—National Institutes of Health, Bethesda, MD University of Cincinnati, Cincinnati, OH
Erwin G. Erpés—Department of Pharmacology, University CHARLES A. NicHoL—Glaxo Research Laboratories, Research
of Illinois, College of Medicine, Chicago, IL Triangle Park, NC
MariA ERECINSKA—University of Pennsylvania, Philadelphia, RoBertT E. Parks, JR—Brown University, Providence, RI
PA GABRIEL L. PLAA—University of Montreal, Quebec, Canada
Ray W. FULLER— Lilly Research Laboratories, Indianapolis, IN a RoBerts—City of Hope Medical Center, Duarte,
RosBert C. GALLO—National Institutes of Health, Bethesda, A
MD JEROME A. RotH—State University of New York, Medical
JAMES R. GILLETTE—National Institutes of Health, Bethesda, Center, Buffalo, NY
CHARLES O. RUTLEDGE—School of Pharmacy, Purdue Univer-
Rosert I. GLAZER—Georgetown University, Washington, DC sity, West Lafayette, IN 47907
I. Davip GOLDMAN—Medical College of Virginia, Richmond, Boris TABAKOFF—National Institutes of Health, Bethesda,
VA
THEODORE E. GRAM—1036 Welsh Drive, Rockville, MD JOHN F. TALLMAN—Yale University, School of Medicine, New
M. R. HANLEY—School of Medicine, University of California, Haven, CT
Davis, CA SNoRRI Sv. THORGEIRSSON—National Institutes of Health,
G. H. HitcHincs—Wellcome Research Laboratories, Research Bethesda, MD
Triangle Park, NC Davip C. U’PrRiICHARD—ICI Americas Inc., Stuart Pharma-
Louis J. IGNARRO—UCLA School of Medicine, Department ceuticals, Wilmington, DE
of Pharmacclogy, Los Angeles, CA —— VAUGHAN—National Institutes of Health, Bethesda,
WILLIAM B. JAkKoBy—National Institutes of Health, Bethesda, D
MD NORMAN WEINER—AbDbott Laboratories, Abbott Park, IL
Davip G. JoHNs—National Institutes of Health, Bethesda, ARNOLD D. WELCH (Chairman)—Frederick Cancer Research
MD Facility of National Cancer Institute, Frederick, MD
Haro_D KALANT— University of Toronto, School of Medicine, JOHN R. WILLIAMSON—University of Pennsylvania, Philadelphia,
Toronto, Ontario, Canada PA
European Continent
F. M. BELPAIRE—J. F. and C. Heymans Institute of Pharma- G. MILLIGAN—Department of Biochemistry, University of
cology, Rijksuniversity, Ghent, Belgium Glasgow, Glasgow, U.K.
A. G. H. BLAKELEY—Department of Physiology, The Univer- P. Mo._peus—Department of Toxicology, Karolinska Insti-
sity, Leicester, U.K. tute, 104 01 Stockholm 60, Sweden
— ea ees of Toxicology, Tiibingen University, G. J. MuL_per—Department of Toxicology, University of
.R.G. Leiden, Sylvius Laboratories, P.O. Box 9503, 2300 RA
J. CALDWELL—St. Mary’s Hospital Medical School, London, Leiden, The Netherlands
K. J. NETTER—Department of Pharmacology and Toxicology,
R.A. J. CHALLIss—Department of Pharmacology, University Philipps University, Marburg, Germany
of Leicester, Leicester, U.K. H. Nout—Institute of Pharmacology and Toxicology, Uni-
T. A. ConNnors—MRC Toxicology Unit, Carshalton, Surrey, versity of Vienna, Vienna, Austria
U.K A. J. Paine—St Bartholomew’s Hospital Medical School,
E. De CLERCQ—Rega Institute for Medical Research, Univer- London, U.K.
sity of Leuven, Belgium B. K. PARK—Department of Pharmacology and Therapeutics,
J. FrereE—Institute de Chimie, Université de Liége, Liége, University of Liverpool, Liverpool, U.K.
Belgium D. V. Parke—Department of Biochemistry, University of
T. GoDFRAIND—Université Catholique de Louvain, Belgium Surrey, Guildford, Surrey, U.K.
R. J. GRYGLEwski—School of Medicine, Cracow, Poland E. Reip>—Guildford Academic Associates, Guildford, Surrey,
J. HAMON—INSERM U288, Neurobiol Cellulaire et Fonc- U.K.
tionnelle, Faculté de Medecine Pitie-Salpetriere, 91 Blvd de E. REINER—Yugoslav Academy of Sciences and Arts, 4100
lH6pital, F-75634 Paris Cedex 14, France Zagreb, Yugoslavia
J. HANOUNE—INSERM U99, H6pital Henri Mondor, Creteil, A. G. ReNwick—University of Southampton, Faculty of
France Medicine, Southampton, U.K.
J. A. HickKMAN—Department of Physiological Sciences, P. J. RopERts—Department of Physiology and Pharmacology,
University of Manchester, Manchester, U.K. Medical and Biological Sciences Building, Southampton,
I. JankU—Institute of Pharmacology, Czechoslovak Academy U.K.
of Sciences, Czechoslovakia M. SANDLER—Bernhard Baron Memorial Research Labora-
P. JENNER—Department of Pharmacology, King’s College, tories, Queen Charlotte’s Maternity Hospital, London, U.K.
London SWS 8AF, U.K. H. Sies—Institut fiir Physiologische Chemie 1, Universitat
H. Kappus—Freie Universitat Berlin, Germany Diisseldorf, Diisseldorf, Germany
J. LuNpDBERG—Department of Pharmacology, Karolinska J. Skopa—Institute of Organic Chemistry and Biochemistry,
Institutet, Stockholm, Sweden Czechoslovak Academy of Sciences, Prague, Czechoslo-
G. P. MANNAERTS—Dienst Farmakoligie, Campus Gasthuis- vakia
berg, Onderwijs en Navorsing, Herestraat, 3000 Leuven, B. Testa—Department of Pharmacy, University of Lausanne,
Belgium Lausanne, Switzerland
D. Mansuy—Universite René Descartes, Laboratoire de K. Tipton—Department of Biochemistry, University of
Chimie et de Biochemie, Pharmacologiques et Toxicolo- Dublin, Trinity College, Ireland
giques, 45 rue des Saints-Péres, 75270 Paris Cedex 05, V. ULtricH—Fakultat fiir Biologie, Universitat Konstanz,
France Konstanz, Germany
A. E. M. McLean—Department of Clinical Pharmacology, P. WALDMEIER—Ciba-Geigy Limited, CH-4002 Basle, Switzer-
University College Hospital Medical School, London, land
U.K M. B. H. Youpivm—Technion-Israel Institute of Technology,
cs MeapE—Department of Pharmacology, Boehringer Faculty of Medicine, Department of Pharmacology, Bat
Ingelheim KG, D-6507 Ingelheim am Rhein, F.R.G. Galim, Haifa, Israel
EDITORIAL ADVISORY BOARD— continued
Asia and Pacific Rim
K. KurtyAMA—Kyoto Prefectural University of Medicine, T. WataBE—Tokyo College of Pharmacy, Tokyo, Japan
Kyoto, Japan
AIMS AND SCOPE
BIOCHEMICAL PHARMACOLOGY is an international journal which publishes original research in the form of
full-length papers, short communications, rapid communications, invited commentaries and meeting reports.
Contributors are asked to note that the Editors will in general accept contributions in English only.
Research with intact animals, cells, subcellular components, enzymes and model systems is acceptable if it
defines the mechanism of drug action. Studies concerned with antimicrobial and antiviral agents are welcomed,
as well as descriptive mathematical models including those involving computer techniques. The use of drugs to
elucidate physiological and behavioural mechanisms in the living organism is also acceptable.
In general, papers which record concentrations of drugs and metabolites in body fluids will not be accepted,
unless they define biochemical and biophysical mechanisms. The Editors however reserve the right to publish
any papers of major interest in the field. The journal publishes the following types of communication:
(1) Full-length Papers. These consist of a body of work presenting original findings relating to the question
proposed by the investigators undertaking the research.
(2) Short Communications. These consist of an original body of work of narrower scope but of the same quality
as the above. By definition, these papers are shorter than full-length manuscripts. The last paragraph of the
communication should summarize the findings of the research.
(3) Rapid Communications. These promote rapid dissemination of timely and significant observations within
the scope of the journal. Manuscripts must be submitted in English and will be judged as appropriate for
publication as rapid communications on the basis of their immediate importance. They should be written to
emphasize clearly the novel aspects of the research. These criteria will be applied strictly. In order to speed up
the publication of rapid communications, authors are encouraged to use the special laysheets available from any
of the Regional Editors.
(4) Commentaries are short commissioned review articles (3000-5000 words in length). They are designed to
be editorial statements on selected topics, and should not be exhaustive reviews. Primarily, Commentaries are
intended to stimulate thought. They can be controversial, and can either focus on areas subject to much activity,
or draw attention to relatively neglected fields in which there are both the opportunity and the need for research
in biochemical pharmacology. Particularly welcome will be Commentaries in which authors present their personal
view on the state of the subject on which they are reporting, and give their view as to where in the near or distant
future the subject may be moving. Authors are especially encouraged to take issue with popular dogmas. The
Commentary series is edited by Professor C. Norman Gillis.
In order to increase the exchange of information and ideas, the Journal will also publish Comments on a
Commentary, in which selected, highly qualified authorities are invited to offer their own observations on
Commentary articles, which will be published in the same issue of the Journal, and thus provide some alternative
thoughts on important areas of research. For further information see Biochem Pharmacol 31, 2568 (1982).
While the final decision on selection of authors for either Commentaries or Comments on a Commentary will
be made at the discretion of the editor, suggestions from readers will be welcome. These should be addressed
to: Professor C. N. Gillis, Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street,
New Haven, Connecticut 06510.
(5) Meeting Reports. The journal is prepared to publish as preliminary communications short, factual two-page
summaries of selected papers from small meetings or conferences. The meetings should be those where attendance
is by invitation and all papers to be published will be refereed. Organizers who wish to have their meetings
published in this way should contact the appropriate Regional Editor.
Policy concerning availability of materials
It is understood that by publishing a paper in Biochemical Pharmacology the authors agree to make freely
available to colleagues in academic research any of the cells, nucleic acids, antibodies, etc. that were used in the
research reported and that are not available from commercial suppliers.
Notes for Contributors can be found in all issues and Abbreviations in issues 1 and 7
CONTENTS OF VOLUME 41
1 JANUARY 1991
Commentaries
Davip McKILLoP and Davin E. CASE Mutagenicity, carcinogenicity and toxicity of B-naphtho-
flavone, a potent inducer of P448
_ JAMES E. HUETTNER Competitive antagonism of glycine at the N-methyl-p-
aspartate (NMDA) receptor
Research Papers
SARITA AGARWAL, USHA R. GUPTA, Susceptibility of glucose-6-phosphate dehydrogenase defi-
CLIVE S. DANIEL, RAM C. GUPTA, cient red cells to primaquine, primaquine enantiomers,
NiTyA ANAND and SHYAM S. AGARWAL and its two putative metabolites. II. Effect on red blood
cell membrane, lipid peroxidation, MC-540 staining, and
scanning electron microscopic studies
VICTOR FERRARI and Davip J. CUTLER Kinetics and thermodynamics of chloroquine and
hydroxychloroquine transport across the human
erythrocyte membrane
JACQUELINE S. WINN, JENNIFER GUILLE, Hydrogen peroxide modulation of the respiratory burst of
JANUSZ M. GEBICKI and human neutrophils
RICHARD O. Day
YACOV ASHANI, SHLOMO SHAPIRA, Butyrylcholinesterase and acetylcholinesterase prophyl-
Drora LEvy, ALAN D. WOLFE, axis against soman poisoning in mice
BEHUPENDRA P. DocTorR and
Lity RAVEH
Logs M. A. SASSEN, Effects of nisoldipine on recovery of coronary blood flow,
KAREL BEZSTAROSTI, sarcoplasmic reticulum function and other biochemical
PiETER.D. VERDOUW and parameters in post-ischaemic porcine myocardium
Jos M. J. LAMERS
ASLE AARSLAND and ROLF K. BERGE Peroxisome proliferating sulphur- and oxy-substituted
fatty acid analogues are activated to acyl coenzyme A
thioesters
Kim PING Won, B. Y. KHoo and Biosynthesis of PAPS in vitro by human liver. Measure-
K. H. Sit ment by two independent assay procedures
KEISUKE EDASHIGE, TOSHIHIKO UTSUMI Inhibition of 12-O-tetradecanoy! phorbol-13-acetate pro-
and Kozo UTsumI moted tumorigenesis by cepharanthine, a biscoclaurine
alkaloid, in relation to the inhibitory effect on protein
kinase C
J. FRANK NASH, RAMESH C. ARORA, Effect of 3,4-methylenedioxymethamphetamine on
MATTHEW A. SCHREIBER and [?H]paroxetine binding in the frontal cortex and blood
HERBERT Y. MELTZER platelets of rats
List of Contents and Author Index for Volume 41, 1991
WILLIAM I. WAITHE, 85 The Ah receptor, cytochrome P4S0IA1 mRNA induction,
MARTIN MICHAUD, and aryl hydrocarbon hydroxylase in a human lympho-
PATRICIA A. HARPER, blastoid cell line
ALLAN B. OKEY and ALAN ANDERSON
GEQRGE W. LUBEGA and 93 Specific interaction of benzimidazole anthelmintics
ROGER K. PRICHARD with tubulin from developing stages of thiabendazole-
susceptible and -resistant Haemonchus contortus
MICHAEL J. TISDALE and 103 Inhibition of tumour-induced lipolysis in vitro and
SusaN A. BECK cachexia and tumour growth in vivo by eicosapentaenoic
acid
PEEYUSH KHANNA, M. B. GUPTA, 109 Influence of chronic oral intake of cannabis extract on
G. P. Gupta, G. G. SANWAL oxidative and hydrolytic metabolism of xenobiotics in rat
and BASHEER ALI
GaLA RAMESH ReEpDpy, NaTtsuo UgeDA; 115 A prenylflavone, artonin E, as arachidonate 5-lipoxy-
TAKAHIKO HaDA, genase inhibitor
ARTHUR COMMY SACKEYFIO,
SHOZO YAMAMOTO, YOSHIO HANO,
Miwa AIDA and TARO NOMURA
ROBERT W. PEOPLES, JAISRI GIRIDHAR 119 y-Aminobutyric acid enhancement of potassium-stimu-
and Gary E. Isom lated release of [*H]norepinephrine by multiple mechan-
isms in rat cortical slices
JEFFREY D. LASKIN and EDMUND LEE 125 Psoralen binding and inhibition of epidermal growth
factor binding by psoralen/ultraviolet light (PUVA) in
human epithelial cells
HaTSuMI AKI and 133 Drug binding to human erythrocytes in the process of
MAGoBEI YAMAMOTO ionic drug-induced hemolysis. Flow microcalorimetric
approaches
Short Communications
T. THOMSEN, B. ZENDEH, J. P. FISCHER 139 Jn vitro effects of various cholinesterase inhibitors on
and H. KewitTz acetyl- and butyrylcholinesterase of healthy volunteers
RONDA J. OTT, ANDREW C. HUI, Interactions of quinidine and quinine and (+)- and (—)-
FEE Mi Wonca, Poge-Hirr Hsyu and pindolol with the organic cation/proton antiporter in renal
KATHLEEN M. GIACOMINI brush border membrane vesicles
MostTaFA Z. BADR 146 Effects of the anti-AIDS drug dideoxyinosine on hepatic
glycolysis in the perfused rat liver: role of intracellular
calcium stores
SOMPON WANWIMOLRUK, 148 Structure-activity relationships for protein binding of a
DONALD J. BIRKETT and series of basic non-steroidal anti-inflammatory drugs
PETER M. BROOKS
PER WALDAY, PAL Aas and Inhibition of serine esterases in different rat tissues follow-
FRODE FONNUM ing inhalation of soman
15 JANUARY 1991
Rapid Communication
STEWART A. METZ and R1_ Inhibition of the metabolism of phosphatidylethanol and
MARJORIE DUNLOP phosphatidic acid, and stimulation of insulin release, by
propranolol in intact pancreatic islets
Commentaries
Moussa B.-H. YoupiM and 155 New directions in monoamine oxidase A and B. Selective
JOHN P. M. FINBERG inhibitors and substrates
FELIX E. SCHWEIZER, THEO SCHAFER 163 Intracellular mechanisms in exocytotic secretion
and Max M. BURGER
List of Contents and Author Index for Volume 41, 1991
Research Papers
SoFIA AVISSAR, DENNIS L. MURPHY 171 Magnesium reversal of lithium inhibition of B-adrenergic
and GABRIEL SCHREIBER and muscarinic receptor coupling to G proteins
P. G. GeRVASI, V. LONGO, F. NALDI, 177 Xenobiotic-metabolizing enzymes in human respiratory
G. PANATTONI and F. UrRsINO nasal mucosa
GEORGE B. FITZGERALD, 185 2,4-Dihydroxybenzylamine: a specific inhibitor of gluta-
CARLA BAUMAN, MD. SaAJJAT HUSSOIN thione reductase
and MICHAEL M. WICK
SHYAM S. CHAUHAN and 191 Elevation of rat pulmonary, hepatic and lung surfactant
Uma K. MIsra lipids by fly ash inhalation
Makoto Nao, SYUN Hosopa, 199 Inhibition of tryptophan hydroxylase by food-derived
MIYUKI OTA, TSUTOMU TAKAHASHI carcinogenic heterocyclic amines, 3-amino-l-methyl-
and TOSHIHARU NAGATSU 5H-pyrido[4,3-b]indole and 3-amino-1,4-dimethyl-5H-
pyrido[4,3-b ]indole
AKIRA SHIRAHATA, TORU MOROHOHI, 205 Putrescine or spermidine binding site of aminopropyl-
MaSAYO FUKAI, SAKAE AKATSU transferases and competitive inhibitors
and KEWJIRO SAMEJIMA
YOUNG-JOON SURH, AMY LIEM, 213 Age- and sex-related differences in activation of the car-
ELIZABETH C. MILLER and cinogen 7-hydroxymethyl-12-methylbenz[a]Janthracene to
JAMES A. MILLER an electrophilic sulfuric acid ester metabolite in rats.
Possible involvement of hydroxysteroid sulfotransferase
activity
BaRRY L. RHINEHART, 223 Quantitative relationship of lysosomal glycogen accumu-
Mary E. BgeGovic and lation to lysosomal «-glucosidase inhibition in castano-
KEITH M. ROBINSON spermine-treated rats
DENNIS E. CHAPMAN, 229 In vivo and in vitro effects of helenalin on mouse hepatic
Davip J. HOLBROOK, microsomal cytochrome P450
STEPHEN G. CHANEY, IRIS H. HALL
and Kuo-HsIunG LEE
U. TRISCHMANN, U. KLOCKNER, 237 Carbon monoxide inhibits depolarization-induced Ca rise
G. ISENBERG, J. UTZ and V. ULLRICH and increases cyclic GMP in visceral smooth muscle cells
PIERRE BOUCHELOUCHE, ELLEN FRICHE, 243 Cytosolic free Ca?* in daunorubicin and vincristine resist-
MAXWELL SEHESTED, ant Ehrlich ascites tumor cells. Drug accumulation is
PETER BUHL JENSEN and independent of intracellular Ca?*+ changes
TORBEN SKOVSGAARD
BRUNO RICHARD, GERARD FABRE, 255 Interspecies variability in mitoxantrone metabolism using
GeEorGES De Sousa, ISABELLE FABRE, primary cultures of hepatocytes isolated from rat, rabbit
ROGER RAHMANI and and humans
JEAN-PAUL CANO
WILLIAM B. MAHONY, 263 Ganciclovir permeation of the human erythrocyte
BARBARA A. DoMIN and membrane
THOMAS P. ZIMMERMAN
JOEL LINDEN, M. RENEE PRATER, 273 Contamination of adenosine deaminase by superoxide
GAIL W. SULLIVAN, ROGER A. JOHNS dismutase. Stabilization of endothelium-derived relaxing
and AMRAT PATEL factor
WEINING ZHEN, Determination of thiazole-4-carboxamide adenine di-
HIREMAGULAR N. JAYARAM nucleotide (TAD) levels in mononuclear cells of leukemic
and GEORGE WEBER patients treated with tiazofurin
DENISE R. SHAW, DONALD R. KNIGHT, 287 3’-Azido-3’-deoxythymidine inhibition of human lympho-
ALICE L. WATERMAN and cyte cytolytic function in vitro
JEAN-PIERRE SOMMADOSSI
VICTORIA L. COHAN, 293 Mechanisms of mediator release from human skin
DONALD W. MACGLASHAN, JR., mast cells upon stimulation by the bradykinin analog,
JANE A. WARNER, [pArg’-Hyp’-] bprPadhykein’in
LAWRENCE M. LICHTENSTEIN
and DaviD PRrouD
Vili List of Contents and Author Index for Volume 41, 1991
Short Communications
Y1 GENG, Eric GHEUENS and 301 Activation and cytotoxicity of 5’-deoxy-5-fluorouridine in
ErnsT A. DE BRUIJN c-H-ras transformed NIH 3T3 cells
HERMINIA PASANTES-MORALES, 303 Hyposmolarity-sensitive release of taurine and free amino
JosE DE JesUs GARCIA and acids from human lymphocytes
ROBERTO SANCHEZ OLEA
GERALD M. RADFORD, 307 Cholesterylsuccinyl-N-hydroxysuccinimide as a cross-
MarIo ARIATTI and linking agent for the attachment of protein to liposomes
ARTHUR O. HAWTREY
FRANCOISE BIERI, VICTOR MEIER, 310 Studies on the mechanism of induction of microsomal
WILLY STAUBLI, cytochrome P452 and peroxisomal bifunctional enzyme
SAMAR F. MUAKKASSAH-KELLY, mRNAs by nafenopin in primary cultures of adult rat
FELIX WAECHTER, hepatocytes
PETER SAGELSDORFF
and PHILIP BENTLEY
FRANCOIS NOEL, MAURICE WIBO 313 Distribution of x1 and a2 (Nat, K*+)-ATPase isoforms
and THEOPHILE GODFRAIND between the junctional (t-tubular) and non-junctional
sarcolemmal domains of rat ventricle
M. KASZKIN, G. FURSTENBERGER 315 Interference of xanthate compounds with phorbol ester
and V. KINZEL TPA-induced changes of phospholipid metabolism: inhi-
bition of prostaglandin production
PAUL WORKMAN, JANE DONALDSON 319 Platelet-activating factor (PAF) antagonist WEB 2086
and MATTHIAS LOHMEYER does not modulate the cytotoxicity of PAF or antitumour
alkyl lysophospholipids ET-18-0-Methyl and SRI 62-834
in HL-60 promyelocytic leukaemia cells
Software Survey Section
1 FEBRUARY 1991
Commentaries
MICHAEL P. GRANT and 323 Unexpected plasticity at autonomic junctions. Environ-
Story C. LANDIS mental regulation of neurotransmitter phenotype and
receptor expression
DANA T. GRAVES and 333 Monocyte chemotactic proteins from human tumor cells
ANTHONY J. VALENTE
Research Papers
PAUL A. HEPBURN and 339 Antitumour imidazotetrazines—XXIV. Growth suppres-
MICHAEL J. TISDALE sion by DNA from cells treated with imidazotetrazinones
ANDERS TUNEK, ELISABETH HJERTBERG 345 Interactions of bambuterol with human serum cholinester-
and JORGEN VIBy MOGENSEN ase of the genotypes E,E, (normal), E,E, (atypical) and
E, E,
ELLEN C. SPOELSTRA, HENK DEKKER, P-glycoprotein drug efflux pump involved in the mechan-
GERRIT JAN SCHUURHUIS, isms of intrinsic drug resistance in various colon cancer
HENRICUS J. BROXTERMAN and cell lines. Evidence for a saturation of active daunorubicin
JAN LANKELMA transport
MAURICE-BERNARD FLEURY, Toward an understanding of the schistosomicidal effect of
MARTINE LARGERON and 4-methyl-5-(2-pyraziny])-1,2-dithiole-3-thione (oltipraz)
THIERRY MARTENS
PIETER J. BOOGAARD, The role of metallothionein in the reduction of cisplatin-
ANJA SLIKKERVEER, induced nephrotoxicity by Bi’*-pretreatment in the rat
J. FRED NAGELKERKE and in vivo and in vitro. Are antioxidant properties of metallo-
GERARD J. MULDER thionein. more relevant than platinum binding?
ILONA FiTos, JULIA Visy and Binding of vinca alkaloid analogues to human serum
MIKLO6Os SIMONYI albumin and to a,-acid glycoprotein
List of Contents and Author Index for Volume 41, 1991
Mary Woops and Mites D. Houstay 385 Desensitization of atriopeptin stimulated accumulation
and extrusion of cyclic GMP from a kidney epithelial cell
line (MDCK)
TAMIE NAKAJIMA, RUI-SHENG WANG, 395 Monoclonal antibody-directed characterization of cyto-
Ervor ELOVAARA, SANG S. PARK, chrome P450 isozymes responsible for toluene metabolism
HARRY V. GELBOIN, EINO HIETANEN in rat liver
and HARRI VAINIO
L. Best, R. TREBILCOCK and 405 Acute stimulation of pancreatic islets by inhibitors of
S. TOMLINSON lactic acid transport
Davip MCKILLoP and 411 Different inhibition and induction profiles of hepatic drug
KATHRYN J. PICKUP metabolism in rats and dogs by two structurally related
pyridyl diazinone cardiotonic agents
TSUTOMU HASHIZUME, 419 Suppressive effect of biscoclaurine alkaloids on agonist-in-
HIROYOSHI YAMAGUCHI, TAKASHI SATO duced activation of phospholipase A, in rabbit platelets
and TATsuzo Fuii
R. M. Linpsay and J. D. BAIRD 425 The effect of diabetes on the in vivo acetylation
capacity of the spontaneously diabetic, insulin-dependent
BB/Edinburgh Wistar rat
Mary VorE, SHERRIE DURHAM, 431 Hepatic clearance and biliary secretory rate maximum of
SIEGFRIED YEH and TANMOY GANGULY taurocholate in the recirculating and single pass isolated
perfused rat liver. Effects of the cholestatic agent, estra-
diol-178 -(B -p-glucuronide)
THomMaS G. Woop, Effect of ultraviolet light on DNA structure in 5-iodo-2’-
MARIA ELENA MARONGIU deoxyuridine-substituted HSV-1 DNA
and WILLIAM H. PRUSOFF
Yus! ABE, KAZUO ICHIHARA and 445 Effects of MCI-176, a new quinazolinone calcium antag-
YASUSHI ABIKO onist, on myocardial energy and carbohydrate metabolism
in ischemic dog hearts
YASUYUKI SUZUKI, 453 Effects of sodium 2-[5-(4-chlorophenyl)pentyljoxirane-2-
NOBUYUKI SHIMOZAWA, carboxylate (POCA) on fatty acid oxidation in fibroblasts
SHIGEHIRO YAJIMA, SEUI YAMAGUCHI, from patients with peroxisomal diseases
TADAO Ort and TAKASHI HASHIMOTO
Short Communications
ROBERT F. STRUCK, 457 Identification of 7-(2-hydroxyethyl)guanine as a product
Jo ANN ALEXANDER, of alkylation of calf thymus DNA with Clomesone
Dorotny M. McCain, |
Y. FULMER SHEALY and Lucy M. ROSE
H.’A. VAN LiTH, G. W. MEER, Serum pseudocholinesterase activity in rabbits fed
M. HALLER and A. C. BEYNEN simvastatin
ZELIHA KOCER, HANNU RAUNIO, Comparison between cobalt and pyrazole in the increased
MARKKU PASANEN, PENTTI ARVELA, expression of coumarin 7-hydroxylase in mouse liver
TERO RAISKILA, PAAVO HONKAKOSKI,
MatTTI A. LANG, MASAHIKO NEGISHI
and OLAVI PELKONEN
JOHN S. PUNZI, SRABANI BANERJEE Structure—activity relationships for various N-alkylcar-
and LEo G. ABoop bamy] esters of choline with selective nicotinic cholinergic
properties
L. RAIMONDI, R. PirRIsINO, G. IGNEsTI, 467 Semicarbazide-sensitive amine oxidase activity (SSAO) of
S. CAPECCHI, G. BANCHELLI and rat epididymal white adipose tissue
F. BUFFONI
Npuna Dzimir! and Amiodarone: biochemical evidence for its interaction with
ABDULRAHMAN A. ALMOTREFI myocardial Na*-K*-ATPase in guinea pig microsomal
preparations
EINOSUKE TANAKA, YOSHIHIKO FUNAE, 472 Characterization of liver microsomal cytochrome P450
SUSUMU IMAOKA and SHOGO MISAWA from .rats treated with muscone (3-methylcyclopenta-
decanone)
BP 41:Index-B
List of Contents and Author Index for Volume 41, 1991
SuSAN M. POND, PAUL R. PENTEL, 473 Determination of the in vivo antigen-antibody affinity
DANIEL E. KEYLER and constant from the redistribution of desipramine in rats
DONALD J. WINZOR following administration of a desipramine-specific mono-
clonal antibody
SWARAJ KAUR, PEEYUSH KHANNA, Selective stimulation of carboxylesterases metabolizing
S. S. PARMAR and BASHEER ALI charged steroid esters by hydrocortisone
15 FEBRUARY 1991
Rapid Communication
Noriko TsuZUKI, TERUO HAMA, Adamantane as a brain-directed drug carrier for poorly
Toru His, Ryoyl KONISHI, absorbed drug: antinociceptive effects of [D-Ala*]Leu-
SHIROH FUTAKI and KOUKI KITAGAWA enkephalin derivatives conjugated with the 1-adamantane
moiety
Commentaries
JOSEPH P. BRESSLER and Mechanisms of lead neurotoxicity
Gary W. GOLDSTEIN
Louis J. IGNARRO Signal transduction mechanisms involving nitric oxide
Research Papers
ADRIANA C. CABALLERO DE CASTRO, Effect of malathion on Bufo arenarum Hensel develop-
ENRIQUE A. ROSENBAUM and ment—I. Esterase inhibition and recovery
ANA M. PECHEN DE D’ANGELO
ROBERTO GAMBARI, Distamycin inhibits the binding of a nuclear factor to the
RAFAELLA BARBIERI, -278/-256 upstream sequence of the human HLA-DRa
CLAUDIO NASTRUZZI, gene
VALERIA CHIORBOLI,
GIORDANA FERIOTTO,
PIER GIORGIO NATALI,
PATRIZIO GIACOMINI and
FEDERICO ARCAMONE
CARMEN MERCADO, FELIX MOLINA, Inhibition of T cell mitogenesis by nitrofurans
JUAN NAVAS, CARMEN QUINONES
and E. H. EYLaR
HaiFa HALLAQ, MICHAEL HELLER, Binding properties and biological effects of oxidized-
RIVKA PANET and YAEL EILAM ouabain on cultured neonatal-rat cardiac myocytes.
Implications on the mechanism of action of the digitalis-
glycosides
MICHAEL R. BOARDER and DEBORAH B. Endothelin-1 stimulation of noradrenaline and adrenaline
MARRIOTT release from adrenal chromaffin cells
FAITH M. WILLIAMS, ELAINE MUTCH Esterase activity in rat hepatocytes
and PETER G. BLAIN
R. J. HopGkiss, A. C. BEGG, Fluorescent markers for hypoxic cells. A study of
R. W. MIDDLETON, J. PARRICK, novel heterocyclic compounds that undergo bio-reductive
M. R. L. STRATFORD, P. WARDMAN binding
and G. D. WILSON
ERLAND J. F. DEMANT Inactivation of cytochrome c oxidase activity in mito-
chondrial membranes during redox cycling of doxorubicin
P. M. DANSETTE, C. AMAR, Hydroxylation and formation of electrophilic metabolites
P. VALADON, C. Pons, of tienilic acid and its isomer by human liver microsomes.
P. H. BEAUNE and D. MAnsuy Catalysis by a cytochrome P450 IIC different from that
responsible for mephenytoin hydroxylation
PETRONELLA C. RAEMAKERS-FRANKEN, In vitro inhibition of cell growth of MOLT-4 malignant
RONNEY A. DE ABREU, human T-lymphoblasts by coenzyme F,4
JOHANNES G. WILLEMS,
CHRIS VAN DER DRIFT and
GODFRIED D. VOGELS